Results 201 to 210 of about 22,974 (229)

Naltrexone

Reactions Weekly, 2011
openaire   +1 more source

Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial

Lancet, The, 2018
Joshua D Lee, Edward V Nunes, Marc Fishman   +2 more
exaly  

Naltrexone

Reactions Weekly, 1999
openaire   +1 more source

Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Lancet, The, 2010
Frank L Greenway, Eduardo Dunayevich
exaly  

Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial

Lancet, The, 2011
Evgeny M Krupitsky, Edward V Nunes, Bernard L Silverman   +2 more
exaly  

Naltrexone

Reactions Weekly, 2019
openaire   +1 more source

A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity‐related risk factors (COR‐II)

Obesity, 2013
Caroline M Apovian, Louis J Aronne, Domenica M Rubino   +2 more
exaly  

Naltrexone

Reactions Weekly, 2016
openaire   +2 more sources

Extended‐release injectable naltrexone for opioid use disorder: a systematic review

Addiction, 2018
Brantley P Jarvis, August F Holtyn, Shrinidhi Subramaniam   +2 more
exaly  

Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR‐BMOD Trial

Obesity, 2011
Thomas A Wadden, Patrick M O'neil, Michael G Perri   +2 more
exaly